XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Financial Royalty Assets, net (formerly known as Commercial License Rights) - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
May 31, 2017
USD ($)
Nov. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Aug. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Oct. 31, 2023
USD ($)
Finite-Lived Intangible Assets                    
Impairment loss of financial royalty assets     $ 0   $ 26,491,000 $ 924,000        
Gross carrying value     210,298,000   210,298,000       $ 70,364,000  
Tolerance Therapeutics (TZIELD)                    
Finite-Lived Intangible Assets                    
Product royalty (as a percent)   1.00%                
Cash payments for acquisition   $ 20,000,000                
Deferred tax liability   $ 5,500,000                
Ovid (Soticlestat)                    
Finite-Lived Intangible Assets                    
Impairment loss of financial royalty assets         26,200,000          
Gross carrying value     $ 4,122,000   $ 4,122,000       30,310,000  
Ovid (Soticlestat) | Discount Rate                    
Finite-Lived Intangible Assets                    
Discount rate (as a percent)     0.17   0.17          
Ovid (Soticlestat) | Soticlestat                    
Finite-Lived Intangible Assets                    
Consideration paid for an interest in potential development milestone                   $ 30,000,000
Interest in sales revenue (as a percent)                   13.00%
Selexis                    
Finite-Lived Intangible Assets                    
Impairment loss of financial royalty assets       $ 900,000 $ 300,000 900,000        
Gross carrying value     $ 242,000   242,000       940,000  
Elutia (CorMatrix)                    
Finite-Lived Intangible Assets                    
Proceeds from royalties received $ 10,000,000                  
Product royalty (as a percent) 5.00%                  
Credit loss adjustment     (300,000) $ 3,200,000 (4,900,000) $ 3,200,000        
Gross carrying value     10,032,000   10,032,000       13,304,000  
Elutia (CorMatrix) | Maximum                    
Finite-Lived Intangible Assets                    
Additional royalties receivable under sales-based milestones $ 10,000,000                  
Ensifentrine inventors                    
Finite-Lived Intangible Assets                    
Gross carrying value     $ 16,018,000   $ 16,018,000   $ 13,600,000 $ 3,800,000 $ 0